SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-24-013458
Filing Date
2024-02-13
Accepted
2024-02-13 17:26:09
Documents
2
Group Members
LAV BIOSCIENCES FUND V SUB A, L.P. LAVVLAV GRANITE LTD GRANYI SHI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea193272-13ga1lavbio5_grace.htm SC 13G/A 118049
2 AGREEMENT OF JOINT FILING ea193272ex99-1_grace.htm EX-99.1 6495
  Complete submission text file 0001213900-24-013458.txt   126378
Mailing Address C/O ESTERA TRUST (CAYMAN) LIMITED 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108
Business Address C/O ESTERA TRUST (CAYMAN) LIMITED 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108 345-640-0540
LAV Biosciences Fund V, L.P. (Filed by) CIK: 0001764435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Subject) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91967 | Film No.: 24630192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)